Modelling coronary heart disease mortality in Northern Ireland between 1987 and 2007: broader lessons for prevention

John Hughes1, Frank Kee, Martin O'Flaherty

  • 1Queen's University, Belfast, UK. john.hughes@qub.ac.uk

Insights

Cardiovascular risk factor changes accounted for 60% of the coronary heart disease mortality decline in Northern Ireland, while treatments contributed 35%. Rising diabetes and obesity rates are a concern.

Area of Science:

  • Cardiovascular epidemiology
  • Public health research
  • Health services research

Background:

  • Coronary heart disease (CHD) mortality has seen significant declines in many developed nations.
  • Understanding the drivers of these declines is crucial for public health policy and intervention strategies.
  • Northern Ireland experienced a notable reduction in CHD mortality between 1987 and 2007.

Purpose of the Study:

  • To determine the proportion of CHD mortality decline attributable to medical/surgical treatments.
  • To quantify the impact of changes in population cardiovascular risk factors on CHD mortality.
  • To analyze trends in risk factors and their contribution to mortality reduction in Northern Ireland.

Main Methods:

  • Utilized the IMPACT mortality model to integrate data from various sources.
  • Incorporated data on treatment uptake, effectiveness, and population risk factor trends (1987-2007).
  • Data sources included mortality statistics, hospital records, primary care data, surveys, and published literature.

Main Results:

  • CHD mortality decreased by 52% in men and 60% in women (aged 25-84) between 1987 and 2007.
  • This decline represented 3180 fewer deaths in 2007 compared to 1987 rates.
  • Risk factor changes explained approximately 60% of the decline, with treatments accounting for 35%.

Conclusions:

  • Major cardiovascular risk factor changes were the primary driver of CHD mortality reduction.
  • Medical and surgical treatments played a significant, but secondary, role in the observed decline.
  • Adverse trends in diabetes, obesity, and physical inactivity pose a significant future concern for cardiovascular health.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results from...